SAT0329 Lesinurad, A Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout: the Crystal Phase III Clinical Trial
暂无分享,去创建一个
R. Terkeltaub | D. Khanna | N. Dalbeth | G. Jones | N. Bhakta | J. Kopicko | C. Storgard | S. Baumgartner | F. Pérez-Ruiz | M. Fung